牛唐2021-03-31 09:44
$灿菲特生物制药(CANF)$ 的药物Piclidenoson和Namodenoson在现有的六份分销协议中,剩余的潜在里程碑付款高达约1.3亿美元,外加两位数的净销售额分成。$新泰医药(MDGL)$ $泰格医药(SZ300347)$查看全文
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-22 AccNo: 0001213900-17-005589 Size: 41 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-05-22 AccNo: 0001213900-17-005595 Size: 62 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-22 AccNo: 0001213900-17-005589 Size: 41 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-16 AccNo: 0001213900-17-005314 Size: 31 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ CT ORDER - Confidential treatment order Filed: 2017-05-04 AccNo: 9999999997-17-005942 Size: 10 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-03 AccNo: 0001213900-17-004530 Size: 49 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-04-25 AccNo: 0001213900-17-004175 Size: 37 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-10 AccNo: 0001214659-17-000930 Size: 68 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-03-31 AccNo: 0001213900-17-003059 Size: 139 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Filed: 2017-03-30 AccNo: 0001213900-17-003022 Size: 3 MB 网页链接